Johnson & Johnson
-
Investing & Wealth
J&J’s Talc Litigation: A Path to Finality?
For years, talc litigation has cast a long shadow over Johnson & Johnson, creating significant uncertainty for investors and a…
Read More » -
Insurance & Protection
J&J’s $5.5 Billion Talc Lawsuit Settlement: A Decade’s End?
Johnson & Johnson has announced an estimated $5.5 billion talc lawsuit settlement, aiming to resolve tens of thousands of claims…
Read More » -
Investing & Wealth
J&J’s $5.5 Billion Talc Lawsuits Settlement: A Costly Resolution?
Johnson & Johnson has announced a significant step towards resolving its long-standing legal challenges, proposing a substantial talc lawsuits settlement…
Read More » -
Insurance & Protection
J&J’s Talc Truce: What Does It Signal for the Casualty Insurance Market?
The recent $5.5 billion settlement by Johnson & Johnson regarding its talc-based baby powder litigation marks a pivotal moment, yet…
Read More » -
Politics & Policy
J&J Talc Deal: Can a $5.5B Settlement Close a Decade of Litigation?
The proposed J&J talc deal, valued at approximately $5.5 billion, signals a potential turning point in a protracted legal saga.…
Read More » -
Insurance & Protection
J&J’s Talc Lawsuits: A $5.5 Billion Path to Resolution?
The long-standing saga of Johnson & Johnson’s talc lawsuits appears to be nearing a definitive financial resolution, with the company…
Read More » -
Insurance & Protection
J&J Talc Litigation: Judge Questions Cancer Causation Evidence
A recent federal court development has cast significant doubt on the scientific basis underpinning thousands of **J&J talc litigation** claims,…
Read More » -
Banks & Payments
FTC Escalates Challenge Over Pharmaceutical Patent Acquisition
The U.S. Federal Trade Commission (FTC) recently urged a federal appeals court to revisit a lower court’s approach to a…
Read More »
